99.69% purity
GLP-1 Agonists
Retatrutide 20mg | ≥99.69% Purity | Most Relevant Trustpilot UK
Retatrutide 20mg — a synthetic triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. ≥99.69% purity (HPLC). Studied in metabolic and incretin pathway research. UK-stocked.
Bundle & save
🚚 Free UK shipping over £100 · dispatched next business day · 🔔 Get stock alerts
- ✓ Independently HPLC + MS verified — per-batch Certificate of Analysis
- ✓ Pay by Bank (Fena / Wallid) or bank transfer (BACS)
⚠ For laboratory research use only. Not for human or veterinary use. Must be 21+ to purchase.
Retatrutide 29mg Research Peptide
Retatrutide is a novel 39-amino acid peptide developed as a triple receptor agonist (GLP-1, GIP, and glucagon receptors). It is supplied as a 30mg lyophilized powder with ≥99.69% purity for advanced laboratory research use. This peptide is widely studied for its roles in metabolic regulation, energy balance, and related pathways in preclinical models.
Key Details
- Quantity: 30mg per vial
- Form: Lyophilized powder (requires reconstitution for research applications)
- Purity: ≥99.69% (HPLC verified)
- Intended Use: For research purposes only — not for human consumption, diagnostic, therapeutic, or any other non-laboratory use.
Important Compliance Note This product is sold strictly for in vitro or laboratory research. It has not been approved by the FDA (or equivalent regulatory bodies) for human use. Always follow all applicable laws and institutional guidelines when conducting research. Suitable for qualified researchers and institutions studying metabolic biology, obesity models, and incretin/glucagon pathways.
Chemical Compound Information
- Chemical Name: Retatrutide (LY3437943)
- Sequence: A modified 39-amino acid peptide with specific fatty acid acylation and amino acid substitutions designed for triple agonism (exact sequence is proprietary but publicly referenced in research literature).
- Molecular Formula: C₂₂₃H₃₄₃N₅₃O₆₆ (approximate for the peptide)
- Molecular Weight: Approximately 4,818 Da (approx.)
- Classification: Synthetic multi-receptor agonist peptide
- CAS Number: 2381089-83-2
Area of Interest Laboratory studies of Retatrutide have investigated a variety of promising areas:
- Metabolic Regulation: Explored as a potent triple agonist for glucose control, appetite suppression, and energy expenditure.
- Weight Management Models: Studied for significant effects on body weight reduction and fat mass in preclinical animal models.
- Incretin & Glucagon Pathways: Investigated for synergistic activation of GLP-1, GIP, and glucagon receptors.
- Cardiometabolic Research: Considered for potential benefits in lipid metabolism, liver health, and cardiovascular parameters in research settings.
Technical Specifications
- Quantity: 20mg
- Form: Lyophilized powder
- Purity: ≥99.69% (HPLC)
- COA: Provided with each batch (includes HPLC chromatogram and mass spectrometry identity confirmation)
Storage Guidelines
- Lyophilized peptide is stable at room temperature for short periods.
- For long-term storage, keep at −20°C or below.
- Once reconstituted, store at 2–8 °C and use within recommended timeframe.